The IL-17 level in all groups before vaccination, as well as after 6 and 12 months, was within the reference values (less than 5 pg/mL), although it was higher in BA patients than in COPD patients and healthy volunteers (Table 7, Fig 3). The gene discussed is IL17A; the disease is chronic obstructive pulmonary disease.